Co-Diagnostics, Inc. Pre-Tax Income
Co-Diagnostics, Inc. (CODX) reported Pre-Tax Income of -$6.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-13
- Co-Diagnostics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$6.26M.
- Co-Diagnostics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$9.14M.
- Co-Diagnostics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$26.22M.
- Co-Diagnostics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$7.05M.
- Co-Diagnostics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$48.51M.
- Co-Diagnostics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$37.58M.
- Co-Diagnostics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$38.11M.
- Co-Diagnostics, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$18.85M, a 141.30% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.26M 10-Q · filed 2026-08-13 | -$15.40M 10-Q · filed 2026-08-13 | -$41.62M derived: sum of 3 quarters · filed 2026-08-13 | -$48.68M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$9.14M 10-Q · filed 2026-05-14 | -$35.36M derived: sum of 2 quarters · filed 2026-05-14 | -$42.41M derived: sum of 3 quarters · filed 2026-05-14 | -$50.13M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$26.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$33.27M derived: sum of 2 quarters · filed 2026-03-31 | -$40.99M derived: sum of 3 quarters · filed 2026-08-13 | -$48.51M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$7.05M 10-Q · filed 2025-11-13 | -$14.77M derived: sum of 2 quarters · filed 2026-08-13 | -$22.29M 10-Q · filed 2025-11-13 | -$33.33M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$7.72M 10-Q · filed 2026-08-13 | -$15.24M 10-Q · filed 2026-08-13 | -$26.28M derived: sum of 3 quarters · filed 2026-08-13 | -$35.95M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$7.52M 10-Q · filed 2026-05-14 | -$18.56M derived: sum of 2 quarters · filed 2026-05-14 | -$28.23M derived: sum of 3 quarters · filed 2026-05-14 | -$35.81M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$20.71M derived: sum of 2 quarters · filed 2026-03-31 | -$28.29M derived: sum of 3 quarters · filed 2026-03-31 | -$37.58M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$9.67M 10-Q · filed 2025-11-13 | -$17.25M derived: sum of 2 quarters · filed 2025-11-13 | -$26.54M 10-Q · filed 2025-11-13 | -$37.38M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$7.58M 10-Q · filed 2025-08-14 | -$16.87M 10-Q · filed 2025-08-14 | -$27.71M derived: sum of 3 quarters · filed 2025-08-14 | -$35.81M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$9.29M 10-Q · filed 2025-05-08 | -$20.13M derived: sum of 2 quarters · filed 2025-05-08 | -$28.23M derived: sum of 3 quarters · filed 2025-05-08 | -$39.38M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | -$10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$18.94M derived: sum of 2 quarters · filed 2025-03-27 | -$30.10M derived: sum of 3 quarters · filed 2025-03-27 | -$38.11M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | -$8.10M 10-Q · filed 2024-11-07 | -$19.25M derived: sum of 2 quarters · filed 2024-11-07 | -$27.27M 10-Q · filed 2024-11-07 | -$52.31M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$11.16M 10-Q · filed 2024-08-08 | -$19.17M 10-Q · filed 2024-08-08 | -$44.22M derived: sum of 3 quarters · filed 2024-08-08 | -$47.69M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$8.02M 10-Q · filed 2024-05-09 | -$33.06M derived: sum of 2 quarters · filed 2024-05-09 | -$36.54M derived: sum of 3 quarters · filed 2024-05-09 | -$39.96M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$25.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$28.52M derived: sum of 2 quarters · filed 2024-03-14 | -$31.95M derived: sum of 3 quarters · filed 2024-03-14 | -$18.85M 10-K · filed 2024-03-14 | ||
| 2022-09-30 | -$3.48M 10-Q · filed 2023-11-09 | -$6.90M derived: sum of 2 quarters · filed 2023-11-09 | $6.20M 10-Q · filed 2023-11-09 | $16.44M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | -$3.43M 10-Q · filed 2023-08-10 | $9.67M 10-Q · filed 2023-08-10 | $19.92M derived: sum of 3 quarters · filed 2023-08-10 | $33.49M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $13.10M 10-Q · filed 2023-05-11 | $23.35M derived: sum of 2 quarters · filed 2023-05-11 | $36.92M derived: sum of 3 quarters · filed 2023-05-11 | $48.85M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $10.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $23.82M derived: sum of 2 quarters · filed 2023-03-16 | $35.75M derived: sum of 3 quarters · filed 2023-03-16 | $45.64M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $13.58M 10-Q · filed 2022-11-10 | $25.51M derived: sum of 2 quarters · filed 2022-11-10 | $35.39M 10-Q · filed 2022-11-10 | $51.20M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $11.93M 10-Q · filed 2022-08-11 | $21.81M 10-Q · filed 2022-08-11 | $37.63M derived: sum of 3 quarters · filed 2022-08-11 | $50.44M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $9.88M 10-Q · filed 2022-05-12 | $25.70M derived: sum of 2 quarters · filed 2022-05-12 | $38.51M derived: sum of 3 quarters · filed 2022-05-12 | $53.52M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $15.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $28.63M derived: sum of 2 quarters · filed 2022-03-24 | $43.63M derived: sum of 3 quarters · filed 2022-03-24 | $42.57M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $12.82M 10-Q · filed 2021-11-12 | $27.82M derived: sum of 2 quarters · filed 2021-11-12 | $26.76M 10-Q · filed 2021-11-12 | $25.02M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $15.01M 10-Q · filed 2021-08-12 | $12.64M 10-Q · filed 2020-08-13 | $13.94M 10-Q · filed 2021-08-12 | $11.57M 10-Q · filed 2020-08-13 | $12.20M derived: sum of 3 quarters · filed 2021-08-12 | $10.46M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$1.07M 10-Q · filed 2021-05-13 | -$2.80M derived: sum of 2 quarters · filed 2021-05-13 | -$4.55M derived: sum of 3 quarters · filed 2021-05-13 | -$5.89M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$3.48M derived: sum of 2 quarters · filed 2021-03-25 | -$4.83M derived: sum of 3 quarters · filed 2021-03-25 | -$6.20M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | -$1.75M 10-Q · filed 2020-11-16 | -$3.09M derived: sum of 2 quarters · filed 2020-11-16 | -$4.46M 10-Q · filed 2020-11-16 | -$6.41M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | -$1.34M 10-Q/A · filed 2020-11-03 | -$2.71M 10-Q/A · filed 2020-11-03 | -$4.66M derived: sum of 3 quarters · filed 2020-11-03 | -$6.30M derived: sum of 4 quarters · filed 2020-11-03 | ||
| 2019-03-31 | -$1.37M 10-Q · filed 2020-05-14 | -$3.32M derived: sum of 2 quarters · filed 2020-05-14 | -$4.96M derived: sum of 3 quarters · filed 2020-05-14 | -$6.33M derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | -$1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$3.59M derived: sum of 2 quarters · filed 2020-03-30 | -$4.96M derived: sum of 3 quarters · filed 2020-03-30 | -$6.27M 10-K · filed 2020-03-30 | ||
| 2018-09-30 | -$1.64M 10-Q · filed 2019-11-12 | -$3.01M derived: sum of 2 quarters · filed 2019-11-12 | -$4.32M 10-Q · filed 2019-11-12 | -$5.83M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | -$1.37M 10-Q · filed 2019-08-14 | -$2.68M 10-Q · filed 2019-08-14 | -$4.19M derived: sum of 3 quarters · filed 2019-08-14 | -$8.08M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | -$1.31M 10-Q · filed 2019-05-14 | -$2.82M derived: sum of 2 quarters · filed 2019-05-14 | -$6.71M derived: sum of 3 quarters · filed 2019-05-14 | -$7.56M derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$5.40M derived: sum of 2 quarters · filed 2019-04-01 | -$6.25M derived: sum of 3 quarters · filed 2019-04-01 | -$6.96M 10-K · filed 2019-04-01 | ||
| 2017-09-30 | -$3.89M 10-Q · filed 2018-11-14 | -$4.75M derived: sum of 2 quarters · filed 2018-11-14 | -$5.45M 10-Q · filed 2018-11-14 | -$5.98M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | -$855.01K 10-Q · filed 2018-08-10 | -$1.56M 10-Q · filed 2018-08-10 | -$2.09M derived: sum of 3 quarters · filed 2018-08-10 | -$2.54M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2017-03-31 | -$705.74K 10-Q · filed 2018-05-14 | -$1.23M derived: sum of 2 quarters · filed 2018-05-14 | -$1.68M derived: sum of 3 quarters · filed 2018-05-14 | -$2.12M derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | -$525.25K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$975.20K derived: sum of 2 quarters · filed 2018-03-28 | -$1.42M derived: sum of 3 quarters · filed 2018-03-28 | -$1.93M 10-K · filed 2018-03-28 | ||
| 2016-09-30 | -$449.95K 10-Q · filed 2017-11-14 | -$892.59K derived: sum of 2 quarters · filed 2017-11-14 | -$1.40M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | -$442.64K 10-Q · filed 2017-08-25 | -$953.49K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |